These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23248416)

  • 21. Zidovudine-induced nail hyper-pigmentation in 45-year-old women prescribed for HIV/tuberculosis co-infection.
    Tandon VR; Sadiq S; Khajuria V; Mahajan A; Sharma S; Gillani Z
    J Midlife Health; 2016; 7(1):38-40. PubMed ID: 27134481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Zidovudine-induced melanonychia].
    Belda A; Borrás-Blasco J; Aragó M; Serra B
    Farm Hosp; 2007; 31(2):128-9. PubMed ID: 17590123
    [No Abstract]   [Full Text] [Related]  

  • 23. Physical signs for the general dental practitioner. Case 49. Zidovudine (AZT or Retrovir) treatment.
    Bain S
    Dent Update; 2007 Nov; 34(9):596. PubMed ID: 18087932
    [No Abstract]   [Full Text] [Related]  

  • 24. Azidothymidine-induced hyperpigmentation mimicking primary adrenal insufficiency.
    Merenich JA; Hannon RN; Gentry RH; Harrison SM
    Am J Med; 1989 Apr; 86(4):469-70. PubMed ID: 2929632
    [No Abstract]   [Full Text] [Related]  

  • 25. Chemotherapy-related striate melanonychia: a case report.
    Hussain F; Gnanappiragasam D; Shaffrali F
    J Med Case Rep; 2021 Jan; 15(1):27. PubMed ID: 33516241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Yellow nail pigmentation following Depakote therapy.
    Buka R; Hille R; McCormack P
    J Drugs Dermatol; 2003 Oct; 2(5):545-7. PubMed ID: 14558403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nail discoloration occurring after 8 weeks of minocycline therapy.
    Ban M; Kitajima Y
    J Dermatol; 2007 Oct; 34(10):699-701. PubMed ID: 17908141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Skin and ungual pigmentation caused by ftorafur].
    Del Pozo LJ; Vilella J; Jimeno M; Del Villar V; Asensio M
    Med Cutan Ibero Lat Am; 1990; 18(1):78-80. PubMed ID: 2214933
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Nail pigmentation during therapy with cyclophosphamide and doxorubicin].
    Manigand G; Faux N; Dumas D; Taillandier J; Fixy P; Richerd F
    Sem Hop; 1983 Jun; 59(24):1840-1. PubMed ID: 6136095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of pigmentary side effects of taxanes and anthracyclines: an onychoscopic evaluation.
    Yorulmaz A; Dogan M; Artuz F; Zengin N
    Cutan Ocul Toxicol; 2017 Jun; 36(2):135-139. PubMed ID: 27086693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disorders of the nails and hair associated with human immunodeficiency virus infection.
    Prose NS; Abson KG; Scher RK
    Int J Dermatol; 1992 Jul; 31(7):453-7. PubMed ID: 1500232
    [No Abstract]   [Full Text] [Related]  

  • 32. 'Fade out' photochromonychia.
    Coulson IH
    Clin Exp Dermatol; 1993 Jan; 18(1):87-8. PubMed ID: 8440066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nail hyperpigmentation secondary to therapy with doxorubicin.
    Giacobetti R; Esterly NB; Morgan ER
    Am J Dis Child; 1981 Apr; 135(4):317-8. PubMed ID: 7211789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Painless periungual pyogenic granulomata associated with reverse transcriptase inhibitor therapy in a patient with human immunodeficiency virus infection.
    Williams LH; Fleckman P
    Br J Dermatol; 2007 Jan; 156(1):163-4. PubMed ID: 17199585
    [No Abstract]   [Full Text] [Related]  

  • 35. Zidovudine/lamivudine for HIV-1 infection contributes to limb fat loss.
    van Vonderen MG; van Agtmael MA; Hassink EA; Milinkovic A; Brinkman K; Geerlings SE; Ristola M; van Eeden A; Danner SA; Reiss P;
    PLoS One; 2009 May; 4(5):e5647. PubMed ID: 19479079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nail discoloration in pediatric skin of color patients.
    Bellet JS
    Pediatr Dermatol; 2021 Nov; 38 Suppl 2():37-41. PubMed ID: 34263476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nevirapine/zidovudine/lamivudine has superior immunological and virological responses not reflected in clinical outcomes in a 48-week randomized comparison with abacavir/zidovudine/lamivudine in HIV-infected Ugandan adults with low CD4 cell counts.
    Munderi P; Walker AS; Kityo C; Babiker AG; Ssali F; Reid A; Darbyshire JH; Grosskurth H; Mugyenyi P; Gibb DM; Gilks CF;
    HIV Med; 2010 May; 11(5):334-44. PubMed ID: 20136661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nail, skin, and scleral pigmentation induced by minocycline.
    Angeloni VL; Salasche SJ; Ortiz R
    Cutis; 1987 Sep; 40(3):229-33. PubMed ID: 3652731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug-induced nail disorders: incidence, management and prognosis.
    Piraccini BM; Tosti A
    Drug Saf; 1999 Sep; 21(3):187-201. PubMed ID: 10487397
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tolerability and effectiveness of first-line regimens combining nevirapine and lamivudine plus zidovudine or stavudine in Cameroon.
    Laurent C; Bourgeois A; Mpoudi-Ngolé E; Ciaffi L; Kouanfack C; Mougnutou R; Nkoué N; Calmy A; Koulla-Shiro S; Delaporte E
    AIDS Res Hum Retroviruses; 2008 Mar; 24(3):393-9. PubMed ID: 18327976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.